Jesper M Weehuizen

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Emergency Department

Randomized Controlled Trial

Coronavirus Disease

Top Venues

Journal of clinical medicine

European journal of clinical investigation

International journal of epidemiology

This page only lists publications with an associated author ORCID identifier.

Publications

Jesper M Weehuizen, Rik van Spronsen, Andy I M Hoepelman, Chantal P Bleeker-Rovers, Jan Jelrik Oosterheert, Peter C Wever
No Influence of Previous Coxiella burnetii Infection on ICU Admission and Mortality in Emergency Department Patients Infected with SARS-CoV-2. Journal of clinical medicine 11 (3) (2022)
Jesper M Weehuizen, Sonja E van Roeden, Sander J Hogewoning, Wim van der Hoek, Marc J M Bonten, Andy I M Hoepelman, Chantal P Bleeker-Rovers, Peter C Wever, Jan Jelrik Oosterheert
No increased risk of mature B-cell non-Hodgkin lymphoma after Q fever detected: results from a 16-year ecological analysis of the Dutch population incorporating the 2007-2010 Q fever outbreak. International journal of epidemiology 51 (5) (2022)
Jesper M Weehuizen, Andy I M Hoepelman
An open-label cluster-randomized controlled trial of chloroquine, hydroxychloroquine or only supportive care in patients admitted with moderate to severe COVID-19 (ARCHAIC)-Protocol publication. European journal of clinical investigation 50 (7) (2020)